DRD2 and hyperprolactinemia: Curiously, both the dissociation and association rates of D2R antagonists used as antipsychotics have been proposed to determine their propensity to cause extrapyramidal side-effects and hyperprolactinaemia (Seeman, 2014; Sykes et al., 2017).